These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
588 related articles for article (PubMed ID: 1474281)
1. Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses. Becx-Bleumink M Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):421-35. PubMed ID: 1474281 [TBL] [Abstract][Full Text] [Related]
2. Relapses in leprosy patients after release from dapsone monotherapy; experience in the leprosy control program of the all Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Becx-Bleumink M Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):161-72. PubMed ID: 1522358 [TBL] [Abstract][Full Text] [Related]
3. Experience with WHO-recommended multidrug therapy (MDT) for multibacillary (MB) leprosy patients in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center in Ethiopia: appraisal of the recommended duration of MDT for MB patients. Becx-Bleumink M Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):558-68. PubMed ID: 1802938 [TBL] [Abstract][Full Text] [Related]
4. Daily multidrug therapy for leprosy; results of a fourteen-year experience. de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752 [TBL] [Abstract][Full Text] [Related]
5. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Becx-Bleumink M; Berhe D Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359 [TBL] [Abstract][Full Text] [Related]
6. Duration of multidrug therapy in paucibacillary leprosy patients; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Becx-Bleumink M Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):436-44. PubMed ID: 1474282 [TBL] [Abstract][Full Text] [Related]
7. Allocation of patients to paucibacillary or multibacillary drug regimens for the treatment of leprosy--a comparison of methods based mainly on skin smears as opposed to clinical methods--alternative clinical methods for classification of patients. Becx-Bleumink M Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):292-303. PubMed ID: 2071986 [TBL] [Abstract][Full Text] [Related]
8. Relapses in paucibacillary leprosy after MDT--a clinical study. Grugni A; Nadkarni NJ; Kini MS; Mehta VR Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):19-24. PubMed ID: 2319185 [TBL] [Abstract][Full Text] [Related]
9. Two microbiological relapses in a patient with lepromatous leprosy. Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984 [TBL] [Abstract][Full Text] [Related]
10. New lesions after MDT in PB and MB leprosy: a report of 28 cases. Kar HK; Sharma P Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355 [TBL] [Abstract][Full Text] [Related]
11. Studies on risk of leprosy relapses in China: relapses after treatment with multidrug therapy. Chen XS; Li WZ; Jiang C; Ye GY Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):379-87. PubMed ID: 10700911 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity. Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255 [TBL] [Abstract][Full Text] [Related]
13. A study on the effectiveness and safety of the WHO/MDT regimen in the northeast of Thailand; a prospective study, 1984-1996. Dasananjali K; Schreuder PA; Pirayavaraporn C Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):28-36. PubMed ID: 9207751 [TBL] [Abstract][Full Text] [Related]
14. Relapses in multibacillary leprosy patients after stopping treatment with rifampin-containing combined regimens. Marchoux Chemotherapy Study Group. Jamet P; Ji B Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):525-35. PubMed ID: 1299707 [TBL] [Abstract][Full Text] [Related]
15. Multidrug therapy in leprosy can prevent relapse--a retrospective study. Biswas S; Mondal KK Indian J Lepr; 2002; 74(4):313-8. PubMed ID: 12624979 [TBL] [Abstract][Full Text] [Related]
16. Incidence of late lepra reaction among multibacillary leprosy patients after MDT. Vijayakumaran P; Manimozhi N; Jesudasan K Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714 [TBL] [Abstract][Full Text] [Related]
17. Risk of relapse in leprosy after fixed-duration multidrug therapy. Li HY; Hu LF; Huang WB; Liu GC; Yuan LC; Jin Z; Li X; Li JL; Yang ZM Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):238-45. PubMed ID: 9251597 [TBL] [Abstract][Full Text] [Related]
18. 10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy. Katoch K; Katoch VM; Natrajan M; Sreevatsa ; Gupta UD; Sharma VD; Shivanavar CT Vaccine; 2004 Sep; 22(27-28):3649-57. PubMed ID: 15315844 [TBL] [Abstract][Full Text] [Related]
19. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy. Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592 [TBL] [Abstract][Full Text] [Related]
20. Relapse of leprosy after multidrug therapy. Dasananjali K J Med Assoc Thai; 1996 Oct; 79(10):635-9. PubMed ID: 8996998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]